About the journal
Annals of Urologic Oncology is an open-access journal published by Asian Medical Press Ltd.(H.K.) in Hong Kong SAR China, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 4 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Asian Medical Press Ltd.(H.K.)
- ISSN
- 2617-7765 · 2617-7773
- Country
- Hong Kong SAR China
- Languages
- english
- Access
- Open access
- Articles in DOAJ
- 122
- Declared review time
- 4 weeks
- Declared peer-review model
- peer_review
- Official website
- http://www.asmepress.com
Index listings
- DOAJ · 2019-06-17
- Indexing
- DOAJ
- APC
- —
- Declared review time (DOAJ)
- 4 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
122
Most recent article
8 months ago
Average review time (journal-declared via DOAJ)
4weeks
Works in OpenAlex
128
Last recorded publication year
2026
h-index
3
i10-index
0
From OpenAlex open data (CC0).
Editorial & policy8
- Last DOAJ review date
- 2023-11-13
- Added to DOAJ
- 2019-06-17
- Declared plagiarism screening
- Not declared
- Other fees beyond APC
- No
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 100%
- ORCID iDs in current deposits
- 0%
- Deposits licence metadata at Crossref
- ✓
- Peer-review policy
- View policy
Identity & continuity2
- Alternate titles
- AUO
- Source type
- journal
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Bladder and Urothelial Cancer Treatments
- Bladder and Urothelial Cancer Treatments
- Prostate Cancer Treatment and Research
- Prostate Cancer Treatment and Research
- Urinary and Genital Oncology Studies
- Urinary and Genital Oncology Studies
- Renal cell carcinoma treatment
- Renal cell carcinoma treatment
Show all subjects (50)
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Diagnosis and Treatment
- Cancer, Lipids, and Metabolism
- Cancer, Lipids, and Metabolism
- Renal and related cancers
- Renal and related cancers
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Urological Disorders and Treatments
- Urological Disorders and Treatments
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- Urologic and reproductive health conditions
- Epigenetics and DNA Methylation
- Urologic and reproductive health conditions
- Cancer Immunotherapy and Biomarkers
- Epigenetics and DNA Methylation
- Cancer Immunotherapy and Biomarkers
- Ferroptosis and cancer prognosis
- Ferroptosis and cancer prognosis
- Testicular diseases and treatments
- Adrenal and Paraganglionic Tumors
- Cancer Genomics and Diagnostics
- Testicular diseases and treatments
- Cancer Genomics and Diagnostics
- Adrenal and Paraganglionic Tumors
- Immunotherapy and Immune Responses
- Genital Health and Disease
- Genital Health and Disease
- Radiopharmaceutical Chemistry and Applications
- Sarcoma Diagnosis and Treatment
- Radiopharmaceutical Chemistry and Applications
- Immunotherapy and Immune Responses
- Sarcoma Diagnosis and Treatment
- Ubiquitin and proteasome pathways
- MicroRNA in disease regulation
- Neuroendocrine Tumor Research Advances
- Ubiquitin and proteasome pathways
- Extracellular vesicles in disease
- Neuroendocrine Tumor Research Advances
- MicroRNA in disease regulation
- Extracellular vesicles in disease
Keywords (DOAJ)
- urologic oncology
- bladder cancer
- prostate cancer
- kidney cancer
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ